natgillin/translations-raw huggingface dataset:
In addition, the Commission shall take into account whether the social harm caused by the new psychoactive substance to individuals and to society is severe, and, in particular, whether the impact of the new psychoactive substance on social functioning and public order is such as to disrupt public order, or cause violent or anti-social behaviour, resulting in harm to the user or to other persons or damage to property, or whether criminal activities, including organised crime, associated with the new psychoactive substance are systematic, involve significant illicit profits or entail significant economic costs.
Komisija poleg tega upošteva, ali je socialna škoda, ki jo nova psihoaktivna snov povzroča posameznikom in družbi, resna, in zlasti ali nova psihoaktivna snov na socialno vedenje in javni red vpliva tako, da povzroča kršenje javnega reda ali nasilno ali asocialno vedenje, kar ima za posledico nastanek škode uporabniku, drugim osebam ali lastnini, oziroma ali so kriminalne dejavnosti, vključno z organiziranim kriminalom, povezane z novo psihoaktivno snovjo, sistematične ter ali vključujejo znatne nedovoljene dobičke ali znatne gospodarske stroške.
If, within six weeks of the date of receipt of the risk assessment report or the combined risk assessment report in accordance with Article 5c(6) of Regulation (EC) No 1920/2006, the Commission considers that it is not necessary to adopt a delegated act to include the new psychoactive substance or substances in the definition of “drug”, it shall present a report to the European Parliament and to the Council explaining the reasons for not doing so.
Če v roku šestih tednov od datuma prejema poročila o oceni tveganja ali skupnega poročila o oceni tveganja, pripravljenega na podlagi člena 5c(6) Uredbe (ES) št. 1920/2006, Komisija ugotovi, da ni treba sprejeti delegiranega akta za vključitev ene ali več novih psihoaktivnih snovi v opredelitev pojma ‚prepovedana droga‘, Evropskemu parlamentu in Svetu predloži poročilo, v katerem pojasni, zakaj tega ne bo storila.
As regards new psychoactive substances added to the Annex to this Framework Decision, Member States which have not yet done so shall bring into force the laws, regulations and administrative provisions necessary to apply the provisions of this Framework Decision to those new psychoactive substances as soon as possible but no later than six months after the entry into force of the delegated act amending the Annex.
V zvezi z novimi psihoaktivnimi snovmi, dodanimi v Prilogo k temu okvirnemu sklepu, države članice, ki tega še niso storile, v najkrajšem možnem času, najpozneje pa v šestih mesecih po začetku veljavnosti delegiranega akta o spremembi Priloge, uveljavijo zakone in druge predpise, potrebne za uporabo določb tega okvirnega sklepa za zadevne nove psihoaktivne snovi.
When Member States adopt those measures, they shall contain a reference to this Framework Decision or be accompanied by such a reference on the occasion of their official publication.
Države članice se v sprejetih predpisih sklicujejo na ta okvirni sklep ali pa sklic nanj navedejo ob njihovi uradni objavi.
Article 1b
Člen 1b
National control measures
Nacionalni nadzorni ukrepi
Without prejudice to the obligations imposed on the Member States under this Framework Decision, Member States may maintain or introduce in their territories, with regard to new psychoactive substances, any national control measures that they consider appropriate.
Države članice lahko brez poseganja v svoje obveznosti iz tega okvirnega sklepa na svojem ozemlju glede novih psihoaktivnih snovi ohranijo ali uvedejo kakršne koli nacionalne nadzorne ukrepe, za katere menijo, da so ustrezni.
‘Article 8a
„Člen 8a
The Commission shall draw up a report in respect of the delegation of power not later than nine months before the end of the five-year period.
Prenos pooblastila iz člena 1a lahko kadar koli prekliče Evropski parlament ali Svet.
The delegation of power shall be tacitly extended for periods of an identical duration, unless the European Parliament or the Council opposes such extension not later than three months before the end of each period.
S sklepom o preklicu preneha veljati prenos pooblastila iz navedenega sklepa.
The delegation of power referred to in Article 1a may be revoked at any time by the European Parliament or by the Council.
Sklep začne učinkovati dan po njegovi objavi v Uradnem listu Evropske unije ali na poznejši dan, ki je določen v navedenem sklepu.
Before adopting a delegated act, the Commission shall consult experts designated by each Member State in accordance with the principles laid down in the Interinstitutional Agreement of 13 April 2016 on Better Law-Making.
Delegirani akt, sprejet na podlagi člena 1a, začne veljati le, če mu niti Evropski parlament niti Svet ne nasprotuje v roku dveh mesecev od uradnega obvestila Evropskemu parlamentu in Svetu o tem aktu ali če pred iztekom tega roka tako Evropski parlament kot Svet obvestita Komisijo, da mu ne bosta nasprotovala.
A delegated act adopted pursuant to Article 1a shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object.
doda se Priloga, kakor je določena v Prilogi k tej direktivi.
That period shall be extended by two months at the initiative of the European Parliament or of the Council.
Člen 2
an Annex, as set out in the Annex to this Directive, is added.
Prenos te direktive
Article 2
Države članice se v sprejetih predpisih sklicujejo na to direktivo ali pa sklic nanjo navedejo ob njihovi uradni objavi.
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 23 November 2018.
Razveljavitev Sklepa 2005/387/PNZ
They shall immediately inform the Commission thereof.
Sklep 2005/387/PNZ se razveljavi z učinkom od 23. novembra 2018.
When Member States adopt those measures, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication.
Ne glede na odstavek 1 se Sklep 2005/387/PNZ še naprej uporablja za nove psihoaktivne snovi, za katere je bilo skupno poročilo iz člena 5 navedenega sklepa predloženo pred 23. novembrom 2018.
Article 3
Komisija sprejme delegirane akte v skladu z odstavki 4 do 8 tega člena o spremembi Priloge k Okvirnemu sklepu 2004/757/PZN, s katerimi se vanjo dodajo nove psihoaktivne snovi iz odstavka 2 tega člena.
Repeal of Decision 2005/387/JHA
Pooblastilo za sprejemanje delegiranih aktov iz odstavka 3 se prenese na Komisijo za obdobje dveh let od 22. novembra 2017.
Decision 2005/387/JHA is repealed with effect from 23 November 2018.
Prenos pooblastila iz odstavka 3 lahko kadar koli prekliče Evropski parlament ali Svet.
Notwithstanding paragraph 1, Decision 2005/387/JHA shall continue to apply to new psychoactive substances in respect of which a joint report, as referred to in Article 5 of that Decision, has been submitted before 23 November 2018.
Sklep začne učinkovati dan po njegovi objavi v Uradnem listu Evropske unije ali na poznejši dan, ki je določen v navedenem sklepu.
The Commission shall adopt delegated acts in accordance with paragraphs 4 to 8 of this Article amending the Annex to Framework Decision 2004/757/JHA in order to add to it new psychoactive substances as referred to in paragraph 2 of this Article.
Delegirani akt, sprejet na podlagi odstavka 3, začne veljati le, če mu niti Evropski parlament niti Svet ne nasprotuje v roku dveh mesecev od uradnega obvestila Evropskemu parlamentu in Svetu o tem aktu ali če pred iztekom tega roka tako Evropski parlament kot Svet obvestita Komisijo, da mu ne bosta nasprotovala.
The power to adopt delegated acts referred to in paragraph 3 shall be conferred on the Commission for a period of two years from 22 November 2017.
Člen 4
The delegation of power referred to in paragraph 3 may be revoked at any time by the European Parliament or by the Council.
Začetek veljavnosti
It shall take effect the day following the publication of the decision in the Official Journal of the European Union or at a later date specified therein.
Ta direktiva začne veljati dan po objavi v Uradnem listu Evropske unije.
A delegated act adopted pursuant to paragraph 3 shall enter into force only if no objection has been expressed either by the European Parliament or the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object.
Člen 5
Article 4
Naslovniki
This Directive shall enter into force on the day following that of its publication in the Official Journal of the European Union.
V Strasbourgu, 15. novembra 2017
Done at Strasbourg, 15 November 2017.
UL C 177, 11.6.2014, str. 52.
For the European Parliament
Stališče Evropskega parlamenta z dne 17. aprila 2014 (še ni objavljeno v Uradnem listu) in stališče Sveta v prvi obravnavi z dne 25. septembra 2017 (še ni objavljeno v Uradnem listu).
The President
Stališče Evropskega parlamenta z dne 24. oktobra 2017 (še ni objavljeno v Uradnem listu).
For the Council
Okvirni sklep Sveta 2004/757/PNZ z dne 25. oktobra 2004 o opredelitvi minimalnih določb glede elementov kaznivih dejanj in kazni na področju nedovoljenega prometa s prepovedanimi drogami (UL L 335, 11.11.2004, str. 8).
OJ C 177, 11.6.2014, p. 52.
Skupni ukrep 97/396/PNZ z dne 16. junija 1997 Sveta na podlagi člena K.3 Pogodbe o Evropski uniji o izmenjavi podatkov, oceni tveganja in nadzoru novih sintetičnih drog (UL L 167, 25.6.1997, str. 1).
Position of the European Parliament of 17 April 2014 (not yet published in the Official Journal) and position of the Council at first reading of 25 September 2017 (not yet published in the Official Journal).
Sklep Sveta 2005/387/PNZ z dne 10. maja 2005 o izmenjavi podatkov, oceni tveganja in nadzoru nad novimi psihoaktivnimi snovmi (UL L 127, 20.5.2005, str. 32).
Position of the European Parliament of 24 October 2017 (not yet published in the Official Journal).
Uredba (EU) 2017/2101 Evropskega parlamenta in Sveta z dne 15. novembra 2017 o spremembi Uredbe (ES) št. 1920/2006 glede izmenjave informacij o novih psihoaktivnih snoveh in sistema zgodnjega opozarjanja na te snovi ter postopka ocene tveganja zanje (glej stran 1 tega Uradnega lista).
Council Framework Decision 2004/757/JHA of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking (OJ L 335, 11.11.2004, p. 8).
UL L 123,12.5.2016, str. 1.
Joint Action 97/396/JHA of 16 June 1997 adopted by the Council on the basis of Article K.3 of the Treaty on European Union, concerning the information exchange, risk assessment and the control of new synthetic drugs (OJ L 167, 25.6.1997, p. 1).
Uredba (ES) št. 1920/2006 Evropskega parlamenta in Sveta z dne 12. decembra 2006 o Evropskem centru za spremljanje drog in zasvojenosti z drogami (UL L 376, 27.12.2006, str. 1).“;
Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances (OJ L 127, 20.5.2005, p. 32).
UL L 123, 12.5.2016, str. 1.“;
Regulation (EU) 2017/2101 of the European Parliament and of the Council of 15 November 2017 amending Regulation (EC) No 1920/2006 as regards information exchange on, and an early warning system and risk assessment procedure for, new psychoactive substances (see page 1 of this Official Journal).
PRILOGA
OJ L 123, 12.5.2016, p. 1.
Seznam snovi iz točke 1(b) člena 1
Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (OJ L 376, 27.12.2006, p. 1).’;
P-metiltioamfetamin ali 4-metiltioamfetamin, kot je naveden v Sklepu Sveta 1999/615/PNZ [1].
OJ L 123, 12.5.2016, p. 1.’;
Parametoksi-metilamfetamin ali N-metil-1-(4-metoksi-fenil)-2-aminopropan, kot je naveden v Sklepu Sveta 2002/188/PNZ [2].
ANNEX
2,5-dimetoksi-4-jodofenetilamin, 2,5-dimetoksi-4-etiltiofenetilamin, 2,5-dimetoksi-4-(n)-propiltiofenetilamin in 2,4,5-trimetoksiamfetamin, kot so navedeni v Sklepu Sveta 2003/847/PNZ [3].
List of substances referred to in point (b) of point 1 of Article 1
enzilpiperazin ali 1-benzil-1,4-diazacikloheksan ali N-benzilpiperazin ali benzilpiperazin, kot je naveden v Sklepu Sveta 2008/206/PNZ [4].
P-Methylthioamphetamine or 4-Methylthioamphetamine, as referred to in Council Decision 1999/615/JHA [1].
etilmetkatinon, kot je naveden v Sklepu Sveta 2010/759/EU [5].
Paramethoxymethylamphetamine or N-methyl-1-(4-methoxyphenyl)-2-aminopropane, as referred to in Council Decision 2002/188/JHA [2].
etil-5-(4-metilfenil)-4,5-dihidrooksazol-2-amin (4,4′-DMAR) in 1-cikloheksil-4-(1,2-difeniletil)piperazin (MT-45), kot sta navedena v Izvedbenem sklepu Sveta (EU) 2015/1873 [6].
2,5-dimethoxy-4-iodophenethylamine, 2,5-dimethoxy-4-ethylthiophenethylamine, 2,5-dimethoxy-4-(n)-propylthiophenethylamine and 2,4,5-trimethoxyamphetamine, as referred to in Council Decision 2003/847/JHA [3].
etilamfetamin, kot je naveden v Izvedbenem sklepu Sveta (EU) 2015/1874 [7].
enzylpiperazine or 1-benzyl-1,4-diazacyclohexane or N-benzylpiperazine or benzylpiperazine, as referred to in Council Decision 2008/206/JHA [4].
odo-2,5-dimetoksi-N-(2-metoksibenzil)fenetilamin (25I-NBOMe), 3,4-dikloro-N-[[1-(dimetilamino)cikloheksil]metil]benzamid (AH-7921), 3,4-metilendioksipirovaleron (MDPV) in 2-(3-metoksifenil)-2-(etilamino)cikloheksanon (metoksetamin), kot so navedeni v Izvedbenem sklepu Sveta (EU) 2015/1875 [8].
ethylmethcathinone, as referred to in Council Decision 2010/759/EU [5].
5-(2-aminopropil)indol, kot je naveden v Izvedbenem sklepu Sveta (EU) 2015/1876 [9].
ethyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45), as referred to in Council Implementing Decision (EU) 2015/1873 [6].
enil-2-(pirolidin-1-il)pentan-1-on (α-pirolidinovalerofenon, α-PVP), kot je naveden v Izvedbenem sklepu Sveta (EU) 2016/1070 [10].
ethylamphetamine, as referred to in Council Implementing Decision (EU) 2015/1874 [7].
Metil 2-[[1-(cikloheksilmetil)-1H-indol-3-karbonil]amino]-3,3-dimetilbutanoat (MDMB-CHMICA), kot je naveden v Izvedbenem sklepu Sveta (EU) 2017/369 [11].
odo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), as referred to in Council Implementing Decision (EU) 2015/1875 [8].
N-(1-fenetilpiperidin-4-il)-N-fenilakrilamid (akriloilfentanil), kot je naveden v Izvedbenem sklepu Sveta (EU) 2017/1774 [12].
5-(2-aminopropyl)indole, as referred to in Council Implementing Decision (EU) 2015/1876 [9].
Sklep Sveta 1999/615/PNZ z dne 13. septembra 1999 o opredelitvi 4-MTA kot nove sintetične droge, za katero veljajo nadzorni ukrepi in kazenske sankcije (UL L 244, 16.9.1999, str. 1).
henyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP), as referred to in Council Implementing Decision (EU) 2016/1070 [10].
Sklep Sveta 2002/188/PNZ z dne 28. februarja 2002 o ukrepih za nadzor in kazenskih sankcijah za novo sintetično drogo PMMA (UL L 63, 6.3.2002, str. 14).
Methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA), as referred to in Council Implementing Decision (EU) 2017/369 [11].
Sklep Sveta 2003/847/PNZ z dne 27. novembra 2003 o ukrepih nadzora in kazenskih sankcijah glede novih sintetičnih drog 2C-I, 2C-T-2, 2C-T-7 in TMA-2 (UL L 321, 6.12.2003, str. 64).
N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), as referred to in Council Implementing Decision (EU) 2017/1774 [12].
Sklep Sveta 2008/206/PNZ z dne 3. marca 2008 o nadzornih ukrepih in kazenskih določbah za novo psihoaktivno snov 1-benzilpiperazin (BZP) (UL L 63, 7.3.2008, str. 45).
Council Decision 1999/615/JHA of 13 September 1999 defining 4-MTA as a new synthetic drug which is to be made subject to control measures and criminal penalties (OJ L 244, 16.9.1999, p. 1).
Sklep Sveta 2010/759/EU z dne 2. decembra 2010 o uvedbi nadzornih ukrepov za 4-metilmetkatinon (mefedron) (UL L 322, 8.12.2010, str. 44).
Council Decision 2002/188/JHA of 28 February 2002 concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA (OJ L 63, 6.3.2002, p. 14).
Izvedbeni sklep Sveta (EU) 2015/1873 z dne 8. oktobra 2015 o uvedbi nadzornih ukrepov za 4-metil-5-(4-metilfenil)-4,5-dihidrooksazol-2-amin (4,4′-DMAR) in 1-cikloheksil-4-(1,2-difeniletil)piperazin (MT-45) (UL L 275, 20.10.2015, str. 32).
Council Decision 2003/847/JHA of 27 November 2003 concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2 (OJ L 321, 6.12.2003, p. 64).
Izvedbeni sklep Sveta (EU) 2015/1874 z dne 8. oktobra 2015 o uvedbi nadzornih ukrepov za 4-metilamfetamin (UL L 275, 20.10.2015, str. 35).
Council Decision 2008/206/JHA of 3 March 2008 on defining 1-benzylpiperazine (BZP) as a new psychoactive substance which is to be made subject to control measures and criminal provisions (OJ L 63, 7.3.2008, p. 45).
Izvedbeni sklep Sveta (EU) 2015/1875 z dne 8. oktobra 2015 o uvedbi nadzornih ukrepov za 4-jodo-2,5-dimetoksi-N-(2-metoksibenzil)fenetilamin (25I-NBOMe), 3,4-dikloro-N-[[1-(dimetilamino)cikloheksil]metil]benzamid (AH-7921), 3,4-metilendioksipirovaleron (MDPV) in 2-(3-metoksifenil)-2-(etilamino)cikloheksanon (metoksetamin) (UL L 275, 20.10.2015, str. 38).
Council Decision 2010/759/EU of 2 December 2010 on submitting 4-methylmethcathinone (mephedrone) to control measures (OJ L 322, 8.12.2010, p. 44).
Izvedbeni sklep Sveta (EU) 2015/1876 z dne 8. oktobra 2015 o uvedbi nadzornih ukrepov za 5-(2-aminopropil)indol (UL L 275, 20.10.2015, str. 43).
Council Implementing Decision (EU) 2015/1873 of 8 October 2015 on subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4′-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) to control measures (OJ L 275, 20.10.2015, p. 32).
Izvedbeni sklep Sveta (EU) 2016/1070 z dne 27. junija 2016 o uvedbi nadzornih ukrepov za 1-fenil-2-(pirolidin-1-il)pentan-1-on (α-pirolidinovalerofenon, α-PVP) (UL L 178, 2.7.2016, str. 18).
Council Implementing Decision (EU) 2015/1874 of 8 October 2015 on subjecting 4-methylamphetamine to control measures (OJ L 275, 20.10.2015, p. 35).
Izvedbeni sklep Sveta (EU) 2017/369 z dne 27. februarja 2017 o uvedbi nadzornih ukrepov za metil 2-[[1-(cikloheksilmetil)-1H-indol-3-karbonil]amino]-3,3-dimetilbutanoat (MDMB-CHMICA) (UL L 56, 3.3.2017, str. 210).
Council Implementing Decision (EU) 2015/1875 of 8 October 2015 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures (OJ L 275, 20.10.2015, p. 38).
Izvedbeni sklep Sveta (EU) 2017/1774 z dne 25. septembra 2017 o uvedbi nadzornih ukrepov za N-(1-fenetilpiperidin-4-il)-N-fenilakrilamid (akriloilfentanil) (UL L 251, 29.9.2017, str. 21).
Council Implementing Decision (EU) 2015/1876 of 8 October 2015 on subjecting 5-(2-aminopropyl)indole to control measures (OJ L 275, 20.10.2015, p. 43).
Pooblastilo za sprejemanje delegiranih aktov iz člena 1a se prenese na Komisijo za obdobje petih let od 22. novembra 2017.
Council Implementing Decision (EU) 2016/1070 of 27 June 2016 on subjecting 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) to control measures (OJ L 178, 2.7.2016, p. 18).
Komisija pripravi poročilo o prenosu pooblastila najpozneje devet mesecev pred koncem petletnega obdobja.
Council Implementing Decision (EU) 2017/369 of 27 February 2017 on subjecting methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) to control measures (OJ L 56, 3.3.2017, p. 210).
Države članice uveljavijo zakone in druge predpise, potrebne za uskladitev s to direktivo, do 23. novembra 2018.
Directive (EU) 2017/2108 of the European Parliament and of the Council
Direktiva (EU) 2017/2108 Evropskega parlamenta in Sveta
amending Directive 2009/45/EC on safety rules and standards for passenger ships
o spremembi Direktive 2009/45/ES o varnostnih predpisih in standardih za potniške ladje
To maintain a high level of safety, and thereby passenger confidence, provided by common safety standards defined by Directive 2009/45/EC of the European Parliament and of the Council [3] and to preserve a level playing field, it is necessary to improve the application of that Directive.
Za ohranitev visoke ravni varnosti in s tem zaupanja potnikov, ki ju zagotavljajo skupni varnostni standardi, opredeljeni v Direktivi 2009/45/ES Evropskega parlamenta in Sveta [3], ter za ohranitev enakih konkurenčnih pogojev bi bilo treba izboljšati uporabo navedene direktive.
Directive 2009/45/EC should apply only to the passenger ships and craft for which the safety standards of that Directive were designed.
Direktiva 2009/45/ES bi se morala uporabljati le za potniške ladje in plovila, za katere so bili zasnovani varnostni standardi, določeni v navedeni direktivi.
A number of specific ship types should therefore be excluded from the scope of that Directive, and in particular tenders, sailing ships and ships transporting, for example to offshore installations, trained personnel who are not engaged in the business of the ship.
Zato bi bilo treba iz področja uporabe navedene direktive izključiti nekatere posebne vrste ladij, zlasti pomožna plovila, jadrnice in ladje, ki prevažajo, denimo k priobalnim napravam, usposobljeno osebje, ki se ne ukvarja z delovanjem ladje.
Ship-carried tenders are used to ferry passengers from passenger ships directly to shore and back, taking the shortest safe sea route.
Pomožna plovila na ladji se uporabljajo za prevoz potnikov od potniških ladij neposredno do obale in nazaj po najkrajši varni morski poti.
They are not appropriate, and should not be used, for other types of services such as coastal sightseeing excursions.
Ta plovila niso ustrezna za druge vrste storitev, kot so denimo turistični izleti ob obali, in se jih ne bi smelo uporabljati v takšne namene.
Such excursions should be undertaken by ships that meet the requirements for passenger ships of the coastal State, as stated, inter alia, by the IMO guidelines (MSC.1/Circ.
Tovrstne izlete bi bilo treba opravljati z ladjami, ki izpolnjujejo zahteve obalne države za potniške ladje, kot je med drugim določeno v smernicah Mednarodne pomorske organizacije (IMO) (MSC.1/Circ.1417 o smernicah za pomožna plovila na potniških ladjah).
1417 on Guidelines for passenger ship tenders).
Države članice in Komisija bi morale spodbujati razpravo v okviru IMO, da bi revidirali smernice in tako povečali varnost.
Member States and the Commission should promote discussion at the IMO with a view to reviewing the guidelines in order to increase safety.
Komisija bi morala oceniti, ali bi morale biti smernice zavezujoče.
The Commission should assess the need to make the guidelines mandatory.
Potniške ladje brez mehaničnega pogona ne spadajo v področje uporabe Direktive 2009/45/ES.
Directive 2009/45/EC excludes passenger ships that are not propelled by mechanical means from its scope.
Jadrnic, katerih mehanični pogon je namenjen le pomožni uporabi in uporabi v sili, se ne bi smelo registrirati v skladu z navedeno direktivo.
Sailing ships should not be certified in accordance with that Directive where their mechanical propulsion is only intended for auxiliary and emergency use.
Zato bi morala Komisija do leta 2020 oceniti potrebo po skupnih evropskih zahtevah za to kategorijo potniških ladij.
The Commission should therefore assess the need for common European requirements for this category of passenger ship by 2020.
Priobalne naprave oskrbujejo plovila, ki prevažajo industrijske delavce.